Get latest articles and stories on Business at LatestLY. New Delhi [India], August 2: Flawless Pharma Private Limited a research-based integrated pharmaceutical company involved in niche API manufacturing & marketing of pharmaceutical ingredient supplier for foremost formulators with services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations with leadership position in Anti Malarial APIs, Anti Cancer APIs, Veterinary APIs has made an announcement today that the company will be investing about USD 100 Million in buyout of assets and patents and has raised money for the long term investments. Business News | Flawless Pharma Pvt Ltd to Invest USD 100 Million in Buyout of Assets & Patents in Hong Kong and China.